Primary gastric non-Hodgkin's lymphoma localized to the gastric wall: no adjuvant treatment following radical surgery

• Published in: Oncology Vol. 51; no. 3; p. 270
• Main Authors: Jelić, S, Kovcin, V, Jovanović, V, Oprić, M, Milanović, N
• Format: Journal Article
• Language: English
• Published: Switzerland 01-05-1994
• Subjects: Adult; Aged; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin - drug therapy; Lymphoma, Non-Hodgkin - radiotherapy; Lymphoma, Non-Hodgkin - surgery; Male; Middle Aged; Stomach Neoplasms - drug therapy; Stomach Neoplasms - radiotherapy; Stomach Neoplasms - surgery; Time Factors
• ISSN: 0030-2414
• DOI: 10.1159/000227347

The paper presents the experience with watch-and-wait policy following radical surgery in 25 patients with primary gastric non-Hodgkin's (NH) lymphoma localized to the gastric wall. The median follow-up is at the moment 40 months (range 18-85). Only 3/25 patients have relapsed (during the first year of the follow-up) and achieved a complete response following chemotherapy. The median disease-free interval following surgery is at the moment 40+ months, and the median survival 40+ months. Primary gastric NH lymphoma localized to the gastric wall, regardless of the histological grade, probably does not need any adjuvant treatment following radical surgery. In occasional patients with lymphoma relapse, the disease can be controlled by additional chemotherapy.